Metraipolis › archive › dc_ec351e2380e8
SGLT2 Inhibitors and the Risk of Infections in Type 2 Diabetes: Systematic Review and Meta-Analyses of Real-World Evidence — Europe PMC PMID:41140367
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41140367
- DOI
- 10.1155/jdr/5888495
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T06:28:52.897Z
- SHA-256 of the archived text
859840377f87c4861a04be3182b9b0c13bc8bc53553b982eb1528fa10ef8e593- Stable URL of this page
https://metraipolis.com/documento/dc_ec351e2380e8
How to cite
SGLT2 Inhibitors and the Risk of Infections in Type 2 Diabetes: Systematic Review and Meta-Analyses of Real-World Evidence — Europe PMC PMID:41140367 — Europe PMC (en), https://europepmc.org/article/MED/41140367 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ec351e2380e8 (Metraipolis archive dc_ec351e2380e8, sha256 859840377f87c4861a04be3182b9b0c13bc8bc53553b982eb1528fa10ef8e593)
BibTeX
@misc{dcec351e2380e8,
title = {SGLT2 Inhibitors and the Risk of Infections in Type 2 Diabetes: Systematic Review and Meta-Analyses of Real-World Evidence — Europe PMC PMID:41140367},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41140367},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ec351e2380e8; sha256 859840377f87c4861a04be3182b9b0c13bc8bc53553b982eb1528fa10ef8e593},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41140367. Agents can read the archived copy with the MCP tool read_document.